tiprankstipranks
Brii Biosciences Limited (HK:2137)
:2137
Hong Kong Market
Want to see HK:2137 full AI Analyst Report?

Brii Biosciences Limited (2137) Financial Statements

2 Followers

Brii Biosciences Limited Financial Overview

Brii Biosciences Limited's market cap is currently HK$967.22M. The company's EPS TTM is HK$-0.2988; its P/E ratio is -4.22; Brii Biosciences Limited is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 18.12M¥ 54.29M¥ 56.32M¥ 51.63M¥ 92.54M
Gross Profit¥ 0.00¥ 54.29M¥ 56.32M¥ 51.63M¥ 92.54M
Operating Income¥ -295.88M¥ -399.50M¥ -544.30M¥ -513.85M¥ -610.48M
EBITDA¥ -290.29M¥ -392.51M¥ -168.20M¥ -503.58M¥ -602.80M
Net Income¥ -216.86M¥ -508.16M¥ -174.83M¥ -484.31M¥ -4.12B
Balance Sheet
Cash & Short-Term Investments¥ 1.94B¥ 2.33B¥ 2.66B¥ 3.00B¥ 3.35B
Total Assets¥ 2.36B¥ 2.71B¥ 3.20B¥ 3.39B¥ 3.61B
Total Debt¥ 8.93M¥ 28.02M¥ 3.16M¥ 12.66M¥ 21.62M
Net Debt¥ -599.70M¥ -975.35M¥ -486.49M¥ -1.18B¥ -2.83B
Total Liabilities¥ 36.22M¥ 100.55M¥ 125.87M¥ 234.35M¥ 300.44M
Stockholders' Equity¥ 2.38B¥ 2.66B¥ 3.12B¥ 3.19B¥ 3.34B
Cash Flow
Free Cash Flow¥ -288.42M¥ -376.12M¥ -643.62M¥ -635.57M¥ -880.49M
Operating Cash Flow¥ -286.55M¥ -372.89M¥ -594.01M¥ -496.28M¥ -879.46M
Investing Cash Flow¥ -151.31M¥ 895.47M¥ -104.35M¥ -1.43B¥ -475.76M
Financing Cash Flow¥ -39.12M¥ -9.41M¥ -10.98M¥ -3.04M¥ 3.23B
Currency in CNY

Brii Biosciences Limited Earnings and Revenue History

Brii Biosciences Limited Debt to Assets

Brii Biosciences Limited Cash Flow

Brii Biosciences Limited Forecast EPS vs Actual EPS